The company also reported a $1.2 million loss for the period. Cash and cash equivalents were reported as $2.7 million, a significant decrease from the same period last year when the company reported $9.2 million in cash and cash equivalents.
In the first quarter, the company sold three Renaissance Systems for minimally invasive and complex spinal surgery. Operating expenses increased during the first quarter of 2012 due to higher sales and marketing costs. The company continues to penetrate new markets in Asia and Europe in addition to expanding its U.S. sales force.
More Articles on Spine Devices:
Orthopaedic Implant Company Launches Pedicle Screw System
14 Spine Devices Receive FDA 510(k) Clearance in April
TranS1 Q1 Revenue Plummets
https://www.beckersorthopedicandspine.com/orthopedic-a-spine-device-a-implant-news/item/11886-trans1-q1-revenue-plummets-26
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.